Reader-Supported · Editorially Reviewed
§ Side-By-Side · GLP-1 Weight Loss

Eden vs Henry Meds: Compounded GLP-1 Compared

Eden and Henry Meds are two of the most established compounded GLP-1 platforms. Eden differentiates with brand-name access (Wegovy, Zepbound, Ozempic, Mounjaro) sitting alongside its compounded line; Henry Meds emphasizes oral-dissolving and sublingual semaglutide options for needle-averse patients.

2 studies cited
Fact-checked 12 May 2026Last updated 12 May 2026Independent Comparison

We may earn a commission through provider links. Matching affiliate offers and editorial priorities affect inclusion and suggested order in commercial guides. Scores are not clinical endorsements. Disclosure · Methodology

Eden and Henry Meds are both compounded GLP-1 specialists with a focus on pricing transparency and affordability. Both platforms prescribe compounded semaglutide and tirzepatide through licensed pharmacy partners and have built their positioning around being the low-cost alternative to brand-name GLP-1s. The key differences are in their pharmacy partnerships, formulary breadth, and clinical oversight model.

Henry Meds has been in the compounded GLP-1 market longer and has a more established track record of pharmacy transparency. Eden is a newer entrant with competitive pricing and a streamlined onboarding process. Both require a licensed prescriber consult before dispensing. The choice between them often comes down to which platform has better pricing at your specific dose tier — both are worth comparing directly before committing.

Eden logo

Eden

GLP-1 Weight Loss · Editor 4.5

Flat upfront pricing with the same dose-equal cost across both compounded and brand-name GLP-1s.

Pricing4.6
Experience4.4
Trust4.5
Read full review
Henry Meds logo

Henry Meds

GLP-1 Weight Loss · Editor 4.6

Affordable subscription telehealth with one of the largest compounded formularies in the industry.

Pricing4.5
Experience4.5
Trust4.5
Read full review
§ Side-by-Side

Side-by-Side Comparison

AttributeEdenHenry Meds
Program FeeNo membership feeIncluded in monthly plan
Medication FromFrom $99/moFrom $179 – $297/mo
Editor Score4.5 / 54.6 / 5
Primary CategoryGLP-1 Weight LossGLP-1 Weight Loss
FDA Brand-Name AccessOzempic, Wegovy, Zepbound, MounjaroKYZATREX
Compounded Options2 compounds9 compounds
Adjacent CategoriesGLP-1 Weight Loss, TRT & Men's Hormones, Women's Health & HRT, Erectile Dysfunction
§ Clinical Evidence

What the Studies Actually Show

Compounded GLP-1 medications are not FDA-approved; they are prepared by 503A or 503B compounding pharmacies under FDA compounding laws and state regulation. Efficacy is inferred from the underlying active ingredient, semaglutide studied in the STEP 1 trial (NEJM 2021) and tirzepatide in SURMOUNT-1 (NEJM 2022). Sublingual and oral-dissolving formulations have less published bioequivalence data than injectable forms.

EndpointEdenHenry Meds
Underlying active ingredientsSemaglutide (compounded + brand) and tirzepatide (compounded + brand)Semaglutide (injectable + sublingual) and tirzepatide (injectable)
Mean weight loss in pivotal trials of the active ingredients1,2Semaglutide 2.4 mg: −14.9% over 68 weeks · Tirzepatide 15 mg: −20.9% over 72 weeksSame, efficacy depends on the molecule, not the brand
Sublingual semaglutide bioavailability3Not offeredLimited published bioequivalence data versus injectable
Brand-name GLP-1 accessWegovy, Zepbound, Ozempic, Mounjaro available as eligible upgradesCompounded only at present
Adjacent formulary (non-GLP-1)LimitedED, TRT, hair loss, and women's hormones available on the same platform

Note on sublingual semaglutide bioavailabilitySublingual and oral-dissolving routes are convenient but have weaker pharmacokinetic evidence than the once-weekly injection studied in the STEP and SUSTAIN trials.

Who Should Choose Eden vs Henry Meds

Choose Eden if…

  • You might switch between compounded and brand-name GLP-1s and don't want a price penalty for it.
  • You want the lowest advertised compounded semaglutide price of the two ($99 a month).

Choose Henry Meds if…

  • You want non-injectable options: Henry offers orally dissolving and sublingual semaglutide.
  • You also need ED or TRT care from the same provider.

Monthly Cost Compared

EdenHenry Meds
Membership or program feeNo membership feeIncluded in monthly plan
Published priceFrom $99/moFrom $179 – $297/mo
All-in at a maintenance doseNot published$197 to $297/mo compounded semaglutide
Public reviews (Trustpilot)4.5/5 from 4,5924.4/5 from 12,520
Prices last checked21 October 202621 October 2026

Prices come from each provider's own pages on the dates shown and change often; maintenance figures include any required membership. Compare every provider in the GLP-1 price tracker.

The Verdict

Choose Eden if you want the option to upgrade to FDA-approved brand-name GLP-1 without changing platforms. Choose Henry Meds for the broader compounded formulary, including ED and TRT, plus oral-dissolving semaglutide.

§ FAQ

Frequently Asked Questions

Is Eden or Henry Meds cheaper for compounded GLP-1?

Pricing is broadly similar (typically $250–$350/mo for compounded semaglutide). Eden's price advantage shows up at higher doses, where its tiered pricing flattens; Henry Meds' price advantage shows up for patients who also need ED, TRT, or hair-loss prescriptions on the same platform. For GLP-1 alone, the price difference is small enough that brand-name access (Eden's strength) and formulary breadth (Henry's strength) are the actual decision factors.

Can I get brand-name Wegovy or Zepbound at Eden?

Yes, Eden offers FDA-approved Wegovy, Zepbound, Ozempic, and Mounjaro alongside its compounded options. This makes Eden one of the few telehealth platforms that lets patients start on compounded for cost reasons and upgrade to brand-name later without changing platforms. Henry Meds does not currently offer brand-name GLP-1 access.

Does Henry Meds offer sublingual or oral-dissolving semaglutide?

Yes, Henry Meds offers sublingual semaglutide as an alternative to injectable for needle-averse patients. Sublingual bioavailability is lower and has weaker pharmacokinetic data than the injectable form studied in the STEP trials, so patients should expect modestly less weight loss. Eden does not currently offer sublingual options.

Which platform has more adjacent prescriptions on the same account?

Henry Meds, it covers ED, TRT, hair loss, and women's hormones on the same platform as GLP-1. Eden's formulary outside GLP-1 is narrower. Patients managing multiple prescriptions benefit from consolidation under Henry Meds; patients focused exclusively on weight loss are well-served by either.

What happens if compounded GLP-1 becomes restricted?

Compounded semaglutide is no longer covered by the FDA shortage exemption (the shortage list was cleared in early 2024). Compounding now relies on the FDCA 503A personalisation exception. Eden's brand-name GLP-1 inventory provides a fallback path; patients on Henry Meds compounded would need to either pay LillyDirect/NovoCare cash-pay rates or switch platforms if their formulation is restricted. Eden's brand-name access is a meaningful insurance policy against further regulatory tightening.

Which platform is better for first-time GLP-1 users?

Eden, the path from compounded to brand-name is cleaner if you're starting GLP-1 and want flexibility to upgrade as your weight loss plateaus or your insurance approves brand-name. Henry Meds is better for experienced GLP-1 users who know they want compounded pricing and value the platform's ED/TRT formulary alongside.

References — Clinical Studies
  1. STEP 1 Trial. NEJM 2021 · Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med 2021;384:989–1002.
  2. SURMOUNT-1 Trial. NEJM 2022 · Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med 2022;387:205–216.

RxNotebook is an editorial publication, not a medical practice. We are not affiliated with the cited studies; source material does not endorse the providers shown. This is general information, not medical advice.

§ Continue Reading